Shilpa Madari
About Shilpa Madari
Shilpa Madari is a Research Scientist with over a decade of experience in the pharmaceutical industry, currently working as a Trial Clinical Pharmacologist at Boehringer Ingelheim in Ridgefield, Connecticut.
Title
Shilpa Madari is a Research Scientist currently holding the position of Trial Clinical Pharmacologist at Boehringer Ingelheim in Ridgefield, Connecticut, United States.
Current Roles at Boehringer Ingelheim
Shilpa Madari holds the role of Trial Clinical Pharmacologist at Boehringer Ingelheim in Ridgefield, Connecticut. She assumed this position in October 2021. Her primary focus in this role includes overseeing clinical trials and contributing to the development of new pharmaceutical products.
Previous Roles at Boehringer Ingelheim
Shilpa has had a substantive tenure at Boehringer Ingelheim, serving in various capacities over the years. She worked as Scientist IV for three months in 2021 and as Scientist III from 2017 to 2021 for four years. Her roles involved extensive research and development within the field of clinical pharmacology.
Experience at Bristol-Myers Squibb
Before her current tenure at Boehringer Ingelheim, Shilpa worked at Bristol-Myers Squibb in several roles. From 2011 to 2016, she served as an Associate Research Scientist II. Prior to this position, she was a Research Scientist from 2010 to 2011. Across these roles, Shilpa gained significant experience in pharmaceutical research and development.
Education and Expertise
Shilpa Madari pursued higher education at the University of New Haven, where she studied from 2008 to 2010. Additionally, her foundational education includes studies at St. Ann's High School. With over a decade of experience in the pharmaceutical industry, Shilpa has developed a strong background in clinical pharmacology and research science.